Preclinical studies linked this effect to the upregulation of HLA molecule expression in tumor cells, favoring increased antigen presentation and activation of antitumor T cells, together with the downregulation of certain immunosuppressive factors such as PD-L1, IL1, IL8, NT5E, and VEGFA [15]. This evidence concerns the gene CD274 and neoplasm.